Cannara Biotech Inc. (TSXV:LOVE)
Canada · Delayed Price · Currency is CAD 1.760
+0.030 (1.73%)
At close: Dec 19, 2025
Cannara Biotech Revenue
In the fiscal year ending August 31, 2025, Cannara Biotech had annual revenue of 107.20M CAD with 31.14% growth. Cannara Biotech had revenue of 28.52M in the quarter ending August 31, 2025, with 23.02% growth.
Revenue
107.20M
Revenue Growth
+31.14%
P/S Ratio
1.56
Revenue / Employee
237.17K
Employees
452
Market Cap
167.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | 107.20M | 25.45M | 31.14% |
| Aug 31, 2024 | 81.75M | 24.49M | 42.77% |
| Aug 31, 2023 | 57.26M | 21.42M | 59.76% |
| Aug 31, 2022 | 35.84M | 18.82M | 110.58% |
| Aug 31, 2021 | 17.02M | 14.47M | 567.24% |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.78B |
| dentalcorp Holdings | 1.66B |
| Trulieve Cannabis | 1.66B |
| Green Thumb Industries | 1.61B |
| Extendicare | 1.59B |
| WELL Health Technologies | 1.25B |
| Sienna Senior Living | 967.05M |
| Canopy Growth | 278.61M |